FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943362359> ?p ?o ?g. }

• W2943362359 endingPage "251" @default.
• W2943362359 startingPage "244" @default.
• W2943362359 abstract "Long-term data comparing partial nephrectomy (PN) and thermal ablation are lacking.To update our experience with PN, percutaneous radiofrequency ablation (RFA), and percutaneous cryoablation for cT1 renal masses.A total of 1798 patients with primary cT1N0M0 renal masses treated between 2000 and 2011 at Mayo Clinic were identified.Percutaneous ablation versus PN.Cancer-specific survival (CSS) was estimated using the Kaplan-Meier method. Local recurrence, metastases, and death from renal cell carcinoma (RCC) were compared with propensity-score-adjusted Cox models.Among 1422 cT1a patients, 1055, 180, and 187 underwent PN, RFA, and cryoablation with median clinical follow-up of 9.4, 7.5, and 6.3yr, respectively. Comparisons of RFA with PN resulted in hazard ratios (HRs) of 1.49 (95% confidence interval [CI] 0.55-4.04, p=0.4), 1.46 (95% CI 0.41-5.19, p=0.6), and 1.99 (95% CI 0.29-13.56, p=0.5) for local recurrence, metastases, and death from RCC. Comparisons of cryoablation to PN resulted in HRs of 1.88 (95% CI 0.76-4.66, p=0.18), 0.23 (95% CI 0.03-1.72, p=0.15), and 0.29 (95% CI 0.01-6.11, p=0.4) for these same outcomes. Five-year CSS was 99%, 96%, and 100% for PN, RFA, and cryoablation, respectively. Among 376 cT1b patients, 324 and 52 underwent PN and cryoablation with median clinical follow-up of 8.7 and 6.0yr, respectively. Comparisons of cryoablation with PN resulted in HRs of 1.22 (95% CI 0.33-4.48, p=0.8), 0.95 (95% CI 0.21-4.38, p>0.9), and 1.94 (95% CI 0.42-8.96, p=0.4) for local recurrence, metastases, and death from RCC, respectively. Five-year CSS was 98% and 91% for PN and cryoablation, respectively. Limitations include retrospective review and selection bias.With mature follow-up at a single institution, percutaneous ablation appears to have acceptable results for cT1 renal tumors and is appropriate for patients with a contraindication for surgery. For cT1a patients, clinically relevant differences between PN and ablation are unlikely, and treatment choice should involve shared decision making. For cT1b patients, death from RCC was more common with cryoablation, and large differences in this outcome cannot be ruled out. Further research is needed to confirm the oncologic effectiveness of cryoablation in the cT1b setting.With appropriate patient triage, partial nephrectomy and percutaneous ablation can be used to treat cT1 renal masses, although additional follow-up and further study are still needed." @default.
• W2943362359 created "2019-05-09" @default.
• W2943362359 creator A5003063527 @default.
• W2943362359 creator A5004426786 @default.
• W2943362359 creator A5005864006 @default.
• W2943362359 creator A5015086487 @default.
• W2943362359 creator A5047776435 @default.
• W2943362359 creator A5060351845 @default.
• W2943362359 creator A5065706799 @default.
• W2943362359 creator A5067675648 @default.
• W2943362359 creator A5067883322 @default.
• W2943362359 creator A5077644150 @default.
• W2943362359 creator A5082725102 @default.
• W2943362359 date "2019-08-01" @default.
• W2943362359 modified "2023-10-09" @default.
• W2943362359 title "Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses" @default.
• W2943362359 cites W1991454984 @default.
• W2943362359 cites W1996859731 @default.
• W2943362359 cites W2013670632 @default.
• W2943362359 cites W2024934637 @default.
• W2943362359 cites W2034558296 @default.
• W2943362359 cites W2041595467 @default.
• W2943362359 cites W2048400969 @default.
• W2943362359 cites W2075830184 @default.
• W2943362359 cites W2078234387 @default.
• W2943362359 cites W2094934590 @default.
• W2943362359 cites W2110681626 @default.
• W2943362359 cites W2115055763 @default.
• W2943362359 cites W2122624137 @default.
• W2943362359 cites W2123344349 @default.
• W2943362359 cites W2132695006 @default.
• W2943362359 cites W2134528893 @default.
• W2943362359 cites W2154644319 @default.
• W2943362359 cites W2156943692 @default.
• W2943362359 cites W2162874327 @default.
• W2943362359 cites W2346399215 @default.
• W2943362359 cites W2515253554 @default.
• W2943362359 cites W2572922053 @default.
• W2943362359 cites W2573152477 @default.
• W2943362359 cites W2610758168 @default.
• W2943362359 cites W2762838246 @default.
• W2943362359 doi "https://doi.org/10.1016/j.eururo.2019.04.026" @default.
• W2943362359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31060824" @default.
• W2943362359 hasPublicationYear "2019" @default.
• W2943362359 type Work @default.
• W2943362359 sameAs 2943362359 @default.
• W2943362359 citedByCount "102" @default.
• W2943362359 countsByYear W29433623592019 @default.
• W2943362359 countsByYear W29433623592020 @default.
• W2943362359 countsByYear W29433623592021 @default.
• W2943362359 countsByYear W29433623592022 @default.
• W2943362359 countsByYear W29433623592023 @default.
• W2943362359 crossrefType "journal-article" @default.
• W2943362359 hasAuthorship W2943362359A5003063527 @default.
• W2943362359 hasAuthorship W2943362359A5004426786 @default.
• W2943362359 hasAuthorship W2943362359A5005864006 @default.
• W2943362359 hasAuthorship W2943362359A5015086487 @default.
• W2943362359 hasAuthorship W2943362359A5047776435 @default.
• W2943362359 hasAuthorship W2943362359A5060351845 @default.
• W2943362359 hasAuthorship W2943362359A5065706799 @default.
• W2943362359 hasAuthorship W2943362359A5067675648 @default.
• W2943362359 hasAuthorship W2943362359A5067883322 @default.
• W2943362359 hasAuthorship W2943362359A5077644150 @default.
• W2943362359 hasAuthorship W2943362359A5082725102 @default.
• W2943362359 hasConcept C126322002 @default.
• W2943362359 hasConcept C126894567 @default.
• W2943362359 hasConcept C141071460 @default.
• W2943362359 hasConcept C207103383 @default.
• W2943362359 hasConcept C2777377203 @default.
• W2943362359 hasConcept C2777472916 @default.
• W2943362359 hasConcept C2777628079 @default.
• W2943362359 hasConcept C2778902805 @default.
• W2943362359 hasConcept C2780091579 @default.
• W2943362359 hasConcept C2780106285 @default.
• W2943362359 hasConcept C2780227381 @default.
• W2943362359 hasConcept C2780813298 @default.
• W2943362359 hasConcept C2781068499 @default.
• W2943362359 hasConcept C44249647 @default.
• W2943362359 hasConcept C50382708 @default.
• W2943362359 hasConcept C71924100 @default.
• W2943362359 hasConceptScore W2943362359C126322002 @default.
• W2943362359 hasConceptScore W2943362359C126894567 @default.
• W2943362359 hasConceptScore W2943362359C141071460 @default.
• W2943362359 hasConceptScore W2943362359C207103383 @default.
• W2943362359 hasConceptScore W2943362359C2777377203 @default.
• W2943362359 hasConceptScore W2943362359C2777472916 @default.
• W2943362359 hasConceptScore W2943362359C2777628079 @default.
• W2943362359 hasConceptScore W2943362359C2778902805 @default.
• W2943362359 hasConceptScore W2943362359C2780091579 @default.
• W2943362359 hasConceptScore W2943362359C2780106285 @default.
• W2943362359 hasConceptScore W2943362359C2780227381 @default.
• W2943362359 hasConceptScore W2943362359C2780813298 @default.
• W2943362359 hasConceptScore W2943362359C2781068499 @default.
• W2943362359 hasConceptScore W2943362359C44249647 @default.
• W2943362359 hasConceptScore W2943362359C50382708 @default.
• W2943362359 hasConceptScore W2943362359C71924100 @default.
• W2943362359 hasIssue "2" @default.
• W2943362359 hasLocation W29433623591 @default.

• next